Midyear 2026 recap: Major clinical findings in optometry

The first half of 2026 delivered a wave of research relevant to myopia management, spanning spectacle lens design, treatment tapering strategies, and mechanistic questions about why myopia progresses. A safety evaluation of red light therapy devices and a case report linking semaglutide to rapid diabetic retinopathy (DR) progression round out a busy 6 months for ODs managing both pediatric and adult patients. Below is a summary of the major findings optometrists should know heading into the second half of the year.